HUTCHMED (China) Ltd at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 07:30PM GMT
Kelly Shi - Jefferies - Moderator

Good afternoon, everyone. Thank you for attending Jefferies' New York Healthcare Conference. We are very pleased to have Mr. Mark Lee, SVP of Corporate Finance and Development, and Ms. Karen Atkin, COO of HUTCHMED, for joining us today to share their insights on HUTCHMED.

Questions and Answers:

Kelly Shi - Jefferies - Moderator

First to start, maybe you can give us a brief overview and the strategy of HUTCHMED, before we get into details in your commercial and clinical pipeline.

Karen Atkin - HUTCHMED(China)Ltd.-COO

Thanks for the opportunity to be here, Kelly.

And yes, so, HUTCHMED, is an innovative biopharma company that's focused on innovative research in oncology and immunology. We've been going as a company for over 20 years now. We're triple listed on Nasdaq, Hong Kong and UK, a market capitalization of about at USD2.1 billion.

And we've been successful with our own research and development. We've got
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot